Atlas Trials

Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer

Clinical trial NCT00262834 · COMPLETED

Trial details

NCT number
NCT00262834
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerStage I Breast CancerStage II Breast CancerStage III Breast Cancer
Start date
2005-10-01
Primary completion
2008-10-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.